Cargando…
Inhibition of JMJD6 by 2‐Oxoglutarate Mimics
Studies on the inhibition of the human 2‐oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2‐oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use...
Autores principales: | Islam, Md. Sailful, Thinnes, Cyrille C., Holt‐Martyn, James P., Chowdhury, Rasheduzzaman, McDonough, Michael A., Schofield, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299220/ https://www.ncbi.nlm.nih.gov/pubmed/34581506 http://dx.doi.org/10.1002/cmdc.202100398 |
Ejemplares similares
-
Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6
por: Islam, Md. Saiful, et al.
Publicado: (2019) -
Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5
por: Islam, Md. Saiful, et al.
Publicado: (2022) -
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
por: Figg, William D., et al.
Publicado: (2021) -
JMJD5 is a human arginyl C-3 hydroxylase
por: Wilkins, Sarah E., et al.
Publicado: (2018) -
Publisher Correction: JMJD5 is a human arginyl C-3 hydroxylase
por: Wilkins, Sarah E., et al.
Publicado: (2018)